Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug ATTO1310 tested for eczema and itch relief

NCT ID NCT06787586

Ongoing Symptom relief Sponsor: Attovia Therapeutics Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new drug called ATTO1310 to see if it is safe and how the body processes it. It includes healthy adults, people with atopic dermatitis (eczema), and those with long-term itching. Participants receive either the drug or a placebo and are monitored for side effects and symptom changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema Pruritus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS (AD) ATOPIC ECZEMA CHRONIC PRURITUS NORMAL VOLUNTEERS

Contacts and locations

Locations

  • Altasciences

    Montreal, Quebec, H3P 3P1, Canada

  • Attovia Clinical Site 102

    Plainfield, Indiana, 46168, United States

  • Attovia Clinical Site 103

    Encinitas, California, 92024, United States

  • Attovia Clinical Site 104

    Saint Joseph, Missouri, 64506, United States

  • Attovia Clinical Site 105

    Montreal, Quebec, H2X2V1, Canada

  • Attovia Clinical Site 106

    Reno, Nevada, 89509, United States

  • Attovia Clinical Site 107

    Sacramento, California, 95815, United States

  • Attovia Clinical Site 108

    San Antonio, Texas, 78213, United States

  • Attovia Clinical Site 109

    Coral Gables, Florida, 33134, United States

  • Attovia Clinical Site 110

    Fredericton, New Brunswick, E3B1G9, Canada

  • Attovia Clinical Site 111

    Newmarket, Ontario, L3Y 5G8, Canada

  • Attovia Clinical Site 112

    Peterborough, Ontario, K9J 5K2, Canada

  • Attovia Clinical Site 113

    Toronto, Ontario, M4W 2N4, Canada

  • Attovia Clinical Site 114

    New York, New York, 10029, United States

  • Attovia Clinical Site 116

    Rocklin, California, 95765, United States

  • Attovia Clinical Site 118

    Margate, Florida, 33063, United States

  • Attovia Clinical Site 119

    New York, New York, 10128, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.